Protagonist Therapeutics Inc (PTGX)
41.23
+0.58
(+1.43%)
USD |
NASDAQ |
Nov 21, 14:25
Protagonist Therapeutics Price: 41.23 for Nov. 21, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
Nov 20, 2024 | 38.29 | 41.18 | 37.80 | 40.65 | 1.048M |
Nov 19, 2024 | 38.27 | 39.82 | 33.31 | 38.65 | 3.046M |
Nov 18, 2024 | 40.98 | 41.05 | 39.70 | 40.39 | 489876.0 |
Nov 15, 2024 | 41.17 | 41.84 | 39.41 | 41.11 | 1.087M |
Nov 14, 2024 | 42.67 | 43.14 | 40.91 | 41.04 | 719217.0 |
Nov 13, 2024 | 43.59 | 43.85 | 42.39 | 42.67 | 594329.0 |
Nov 12, 2024 | 46.12 | 46.64 | 42.95 | 43.17 | 652874.0 |
Nov 11, 2024 | 46.90 | 48.35 | 46.43 | 46.50 | 558206.0 |
Nov 08, 2024 | 48.86 | 48.86 | 45.23 | 46.23 | 682762.0 |
Nov 07, 2024 | 47.43 | 48.69 | 46.53 | 47.61 | 427884.0 |
Nov 06, 2024 | 48.16 | 48.67 | 46.39 | 47.60 | 1.081M |
Nov 05, 2024 | 47.15 | 47.31 | 43.86 | 45.90 | 848588.0 |
Nov 04, 2024 | 46.30 | 47.76 | 45.36 | 46.76 | 375845.0 |
Nov 01, 2024 | 46.11 | 47.02 | 45.99 | 46.76 | 422357.0 |
Oct 31, 2024 | 47.18 | 47.32 | 45.65 | 45.84 | 439776.0 |
Oct 30, 2024 | 48.01 | 48.30 | 47.44 | 47.62 | 286069.0 |
Oct 29, 2024 | 47.95 | 48.62 | 47.58 | 48.43 | 312801.0 |
Oct 28, 2024 | 47.69 | 48.89 | 47.35 | 48.20 | 356196.0 |
Oct 25, 2024 | 47.30 | 47.95 | 46.84 | 47.26 | 300209.0 |
Oct 24, 2024 | 46.71 | 47.30 | 46.34 | 46.95 | 283761.0 |
Oct 23, 2024 | 46.31 | 46.68 | 45.48 | 46.59 | 415613.0 |
Oct 22, 2024 | 45.38 | 46.53 | 45.33 | 46.44 | 310130.0 |
Oct 21, 2024 | 46.80 | 47.03 | 45.51 | 45.96 | 439589.0 |
Oct 18, 2024 | 47.20 | 47.53 | 46.69 | 46.97 | 588702.0 |
Oct 17, 2024 | 47.11 | 47.54 | 46.68 | 47.02 | 554547.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
4.69
Minimum
Dec 03 2019
49.69
Maximum
Sep 01 2021
22.85
Average
21.80
Median
Dec 19 2023
Price Benchmarks
Johnson & Johnson | 155.58 |
Assembly Biosciences Inc | 14.73 |
Precision BioSciences Inc | 6.60 |
Entrada Therapeutics Inc | 18.13 |
NovaBay Pharmaceuticals Inc | 0.70 |
Price Related Metrics
PE Ratio | 15.50 |
PS Ratio | 7.866 |
Price to Book Value | 4.620 |
Price to Free Cash Flow | 11.11 |
Earnings Yield | 6.45% |
Market Cap | 2.457B |
Operating PE Ratio | 17.08 |
Normalized PE Ratio | 15.50 |